The department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, uses Diffuse Noxious Inhibitory Control Assessment (DNIC) among their pain testing protocols when researching the Paradigm for Prediction of Post-Operative Pain in order to identify patients at risk of developing chronical pain. The DNIC protocol is performed using Medoc Pathway device thermode to produce heat pain test stimulus and a hot-water bath as a conditioning stimulus. The DNIC procedure allows the researchers to evaluate the functionality of inhibitory pathway of the pain modulatory system.
Pathway Model CHEPS (Contact Heat-Evoked Potential Stimulator) is considered the most advanced and sophisticated device for pain assessment available today. It is an advanced thermal stimulator for pain evoked-potentials able to deliver rapid and accurate heat. Pathway Model CHEPS provides exciting opportunities in the field of pain research. For further reading on, click here